Evolving expectations around early management of multiple sclerosis. - Wikidata - wikimedia - TriplyDB

Evolving expectations around early management of multiple sclerosis.

Evolving expectations around early management of multiple sclerosis.

http://www.wikidata.org/entity/Q34409412

about

Decoding the complexity of type I interferon to treat persistent viral infections Survey of US Patients with Multiple Sclerosis: Comparison of the New Electronic Interferon Beta-1b Autoinjector (BETACONNECT™) With Mechanical Autoinjectors Headaches in multiple sclerosis patients might imply an inflammatorial process.Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC)Radiologically isolated syndrome: watchful waiting vs. active treatment.Redox processes in neurodegenerative disease involving reactive oxygen species Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis Cognitive functions over the course of 1 year in multiple sclerosis patients treated with disease modifying therapies Future of management of multiple sclerosis in the middle East: a consensus view from specialists in ten countries.CD40-Mediated NF-κB Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics.Treatment of cognitive impairment in multiple sclerosis: position paper.Characteristics of multiple sclerosis in the Middle East with special reference to the applicability of international guidelines to the region.Effectiveness of multiple sclerosis treatment with current immunomodulatory drugs.Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review.The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis.Cytokine Signaling in Multiple Sclerosis and Its Therapeutic Applications.Reports of patients and relatives from the CogniCIS study about cognition in clinically isolated syndrome: what are our patients telling us?Lower 25-Hydroxyvitamin D Is Associated with Higher Relapse Risk in Patients with Relapsing-Remitting Multiple Sclerosis.Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis.Daclizumab for the treatment of adults with relapsing forms of multiple sclerosis.Relapsing-Remitting Multiple Sclerosis diagnosis from cerebrospinal fluids via Fourier transform infrared spectroscopy coupled with multivariate analysis.

P2860

Q27023801-6369ED61-A3E2-4D08-9ABC-CBAF1BC18D83 Q30830291-F044D789-8159-4707-A4E3-D87AC2E86A67 Q34934506-61FB115E-FC5F-4D3D-B27B-75FFB97A10B0 Q36077974-2300CC1F-9CCA-49D1-A662-923FDFAE3AE7 Q36188305-60DD83A4-A7B4-44B6-8CBB-E1826660481C Q36460613-3933D317-9702-424B-AB56-BC1E04F8F886 Q36618676-4BF61958-88BD-414D-9943-483AAE325048 Q37027697-BEE079AE-A460-4DE2-9C2B-A7D2A2610D92 Q37424282-42263D67-59EC-4DE0-ACEB-0DCBF5C0D85E Q37645910-DB3024C3-ADA7-4785-8E9D-4C18F993468E Q38062466-FC86EF06-B912-4CC7-9604-08DF84A31227 Q38162468-9399CD87-77D4-483C-B5F0-88B999C0BFB7 Q38315992-D2925B39-9BBC-4A13-AF69-863AA6F7DD33 Q38625426-5B9D9DBE-9BDC-41EA-BAE1-C2AD85F425CE Q38910574-BB6D2565-04DC-4020-A9B1-DAA834F5FA4E Q42361828-D91CE1EF-C48E-4ADE-BD63-7DC84DC693C3 Q45071794-2B4C03DA-C519-43EA-864D-BEBDECCB6A76 Q46043515-7845E4C4-47E9-4D98-90EE-3A8A8B5A6FBF Q47210452-186A4322-94FF-414A-B46C-7246FBAAC73D Q47908989-B9087097-7FF5-4410-AA90-D40C323387C4 Q47959279-634DC59D-0C6C-4B20-A418-2521CCD7B2D9 Q49269072-92DD3066-D347-4CC8-8AFA-149471683C83

P2860

Evolving expectations around early management of multiple sclerosis.

http://www.wikidata.org/entity/Q34409412

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Evolving expectations around early management of multiple sclerosis.

@ast

Evolving expectations around early management of multiple sclerosis.

@en

Evolving expectations around early management of multiple sclerosis.

@nl

type

label

Evolving expectations around early management of multiple sclerosis.

@ast

Evolving expectations around early management of multiple sclerosis.

@en

Evolving expectations around early management of multiple sclerosis.

@nl

prefLabel

Evolving expectations around early management of multiple sclerosis.

@ast

Evolving expectations around early management of multiple sclerosis.

@en

Evolving expectations around early management of multiple sclerosis.

@nl

P1433

Q34409412-C4A2EDEC-F5E5-4123-AEE5-5EAA2839A9CA

P1476

Q34409412-E628F8A6-39F5-4A1A-BC6F-C14301220AC3

P2093

Q34409412-0FBABC81-B6F7-4BF9-B0C8-8A93D02B4867

Q34409412-84D1FE48-DD79-4EA0-A7BE-D954A22FEFEE

P2860

Q34409412-00EF69F8-4293-40CC-B252-F9765884C709

Q34409412-04D88964-1080-476A-8562-84F6FAF08686

Q34409412-06071D9C-2B0A-4057-A37F-21CDCD8D8D46

Q34409412-08047B1B-D053-44A6-ACAB-028D61D22E4D

Q34409412-09188699-DF3A-409E-A8E1-5D96BE74B33F

Q34409412-0A95B111-0B15-4AD4-99D9-909C345F8DE6

Q34409412-0AF05BE3-0E93-4F8B-B026-F9FC9FBBB990

Q34409412-0AF93F1E-D7E0-4C5F-8EBE-CDBFD2FDFAE6

Q34409412-0B25A6FB-C58D-4D65-85F2-4FEA633E3216

Q34409412-10A1D2B9-2635-438D-A7F4-E12D4E096D12

P304

Q34409412-953755C1-888C-4C20-B352-7322749A2FEC

P31

Q34409412-3f07156a-612a-4f62-bf2f-69fc8b868a1f

Q34409412-FC942996-1956-462A-A3A4-DFA07D630FE5

P356

Q34409412-5374CA59-35B6-4A8E-8358-4FDE448847A1

P433

Q34409412-5D25D8BD-7319-4C28-8103-0194440C545D

P478

Q34409412-0982814C-4A69-413C-8F7C-16FF64112DF1

P50

Q34409412-9329FCCA-BFCD-4C1A-8862-CAD588742EAA

Q34409412-E7A35364-3CD1-470E-84B8-D2791F7B07F8

P577

Q34409412-58DA7E8C-6DC8-4C14-AE91-5E257ADC3136

P5875

Q34409412-8591B213-5DB0-451D-9976-A0F4ADA9570F

P698

Q34409412-6B472096-4F3E-4109-8B8D-58F831525C63

P921

Q34409412-A118FF5B-D2A5-4123-8763-68F80CB0FF03

P932

Q34409412-34877F43-2A69-4FCE-9C20-A11BBA719830

P356

1756285610385608

P1433

Therapeutic advances in neurological disorders

P1476

Evolving expectations around early management of multiple sclerosis.

@en

P2093

Jerry S Wolinsky

http://www.w3.org/2001/XMLSchema#string

Ralf Gold

http://www.w3.org/2001/XMLSchema#string

P2860

The OXR domain defines a conserved family of eukaryotic oxidation resistance proteins

Defining the clinical course of multiple sclerosis: Results of an international survey

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis

ERAP140, a conserved tissue-specific nuclear receptor coactivator.

Metallothionein-III protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a PI3K and ERK/Nrf2-dependent manner

Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years

Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis

Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile

P304

351-367

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1756285610385608

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Maria Pia Amato

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49703576

http://www.w3.org/2001/XMLSchema#string

P698

21179596

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

3002639

http://www.w3.org/2001/XMLSchema#string